RNS Number : 2371O
Ananda Developments PLC
14 May 2024
 

14 May 2024

 

ANANDA DEVELOPMENTS PLC

("Ananda" or the "Company")

 

Ananda Presentation to LSX Conference 2024

 

Ananda Developments plc (AQSE: ANA), a company focused on becoming a leading provider of CBD-based medicines for chronic inflammatory pain conditions, recently presented to life science industry leaders at the 10th LSX World Congress in London.

The LSX World Congress is the leading partnering, strategy and investment event in Europe for life science executives, offering networking opportunities and discussions on the latest industry trends and innovations.

Jeremy Sturgess-Smith, Ananda Finance Director, delivered a comprehensive presentation to potential investors and other industry leaders, showcasing the Company's progress in developing patent pending CBD formulations as regulated drugs for chemotherapy induced peripheral pain and endometriosis.   

 

Ananda CEO Melissa Sturgess commented "CBD is a multi-modal molecule and shows great potential for treating people with chronic indications at a time when the NHS is overwhelmed and we have many people unable to go to work.  We believe our drug development is happening just at the right time."

 

The presentation has been uploaded on Ananda's website and can be found via the following link: https://investors.anandadevelopments.com/activity-updates

 

About Ananda Developments

Ananda is an AQSE-listed company whose ambition is to be a leading provider of cannabinoid-based medicines for the treatment of complex, chronic inflammatory pain conditions.

 

For further information on the Company visit https://anandadevelopments.com/ or sign up at https://investors.anandadevelopments.com/s/a66906.

 

For more information please contact:

 

InvestorHub

Engage with us directly at Ananda Developments Investor Hub

 

 

 

Sign up at https://investors.anandadevelopments.com/s/a66906

 

 

ANANDA DEVELOPMENTS PLC

Chief Executive Officer

Melissa Sturgess

Executive Director

Jeremy Sturgess-Smith

 

+44 (0)7463 686 497 ir@anandadevelopments.com

SP ANGEL CORPORATE FINANCE LLP

Corporate Finance

Richard Morrison

Caroline Rowe

 

+44 (0)20 3470 0470

Corporate Broking

Abigail Wayne

Rob Rees

 


Yellow Jersey PR

Charles Goodwin

Zara McKinlay

+44 (0)20 3004 9512

 

https://investors.anandadevelopments.com/link/7eXQkr

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUOVVRSKUVAAR
Ana Hldgs (LSE:ANA)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024 Haga Click aquí para más Gráficas Ana Hldgs.
Ana Hldgs (LSE:ANA)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024 Haga Click aquí para más Gráficas Ana Hldgs.